Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Ri-Sheng Yu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2428-0268; OpenAlex author ID A5101952808. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. A nomogram for predicting the disease-free survival of patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12880-026-02301-7↗
  2. Modified-FOLFIRINOX in metastatic pancreatic cancer: A prospective study in Chinese population. Co-author DOI 10.1016/j.canlet.2017.07.012↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yao Pan · 1 shared paper, 2026 · strength 0.39
  2. Ting-Bo Liang · 1 shared paper, 2017 · strength 0.05
  3. Ying Yuan · 1 shared paper, 2017 · strength 0.05
  4. Xiang Li · 1 shared paper, 2017 · strength 0.05
  5. Tao Ma · 1 shared paper, 2017 · strength 0.05
  6. Risheng Que · 1 shared paper, 2017 · strength 0.05
  7. Qi Zhang · 1 shared paper, 2017 · strength 0.05
  8. Lei Zheng · 1 shared paper, 2017 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.